Researchers from the Wuhan Institute of Virology in China have discovered a new strain of the coronavirus in bats, which ...

A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the SARS-CoV-2 virus ...

Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%.

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...

Shares of Novavax Inc. NVAX slipped 1.25% to $7.92 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.47% to 19,962.

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

The Centers for Disease Control and Prevention (CDC) and District Health Department #10 (DHD#10) have announced updated COVID-19 vaccine recommendations.

The stock's fall snapped a three-day winning streak.

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...

Every fall and winter, the United States sees an uptick in the number of people who fall ill to influenza and other seasonal diseases. This flu season typically stretches from October to ...